Product Wiki · Recalls · Health Canada — Medical Devices

Beckman Coulter Access Erythropoetin Reagent — recall 77250

Health Canada — Medical Devices · Canada · 2025-04-09 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →

Agency: Health Canada — Medical Devices
Recall identifier: 77250
Date of alert: 2025-04-09
Country / jurisdiction: Canada
Risk level: Type II
Risk type: recall
Product category: Chemistry - Haematology
Product type: Medical devices

Reported risk: Beckman Coulter has determined that the affected access erythropoietin (EPO) reagent lot number exhibits an approximate concentration bias of ~-22% with patient samples when compared to alternate EPO reagent lots. Recall start date: February 3, 2025

Primary source: https://recalls-rappels.canada.ca/en/alert-recall/beckman-coulter-access-erythro

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Beckman Coulter Access Erythropoetin Reagent — recall 77250

Related